Multiple Endocrine Neoplasia Treatment Market, Global Outlook and Forecast 2022-2028

April 2022 | 61 pages | ID: M91A3058AE0EEN
Market Monitor Global

Abstracts

Multiple Endocrine Neoplasia is a disease caused by genetic mutation. Multiple Endocrine Neoplasia is inherited from one generation to another generation. The symptoms of the multiple endocrine neoplasia depends on the type of gland which is affected by the disease. The multiple endocrine neoplasia has been classified according to the gland which is affected by the disease.

This report contains market size and forecasts of Multiple Endocrine Neoplasia Treatment in Global, including the following market information:

Global Multiple Endocrine Neoplasia Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Multiple Endocrine Neoplasia Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Drug Treatment Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Multiple Endocrine Neoplasia Treatment include West Coast Pharmaceuticals, Solvay, Unicure India, Sun Pharmaceuticals Industries and Macleods Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Multiple Endocrine Neoplasia Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Multiple Endocrine Neoplasia Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Multiple Endocrine Neoplasia Treatment Market Segment Percentages, by Type, 2021 (%)

• Drug Treatment
• Surgery Treatment

Global Multiple Endocrine Neoplasia Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Multiple Endocrine Neoplasia Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinic
• Others

Global Multiple Endocrine Neoplasia Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Multiple Endocrine Neoplasia Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Multiple Endocrine Neoplasia Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Multiple Endocrine Neoplasia Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• West Coast Pharmaceuticals
• Solvay
• Unicure India
• Sun Pharmaceuticals Industries
• Macleods Pharmaceuticals

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Multiple Endocrine Neoplasia Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Multiple Endocrine Neoplasia Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL MULTIPLE ENDOCRINE NEOPLASIA TREATMENT OVERALL MARKET SIZE

2.1 Global Multiple Endocrine Neoplasia Treatment Market Size: 2021 VS 2028
2.2 Global Multiple Endocrine Neoplasia Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Multiple Endocrine Neoplasia Treatment Players in Global Market
3.2 Top Global Multiple Endocrine Neoplasia Treatment Companies Ranked by Revenue
3.3 Global Multiple Endocrine Neoplasia Treatment Revenue by Companies
3.4 Top 3 and Top 5 Multiple Endocrine Neoplasia Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Multiple Endocrine Neoplasia Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Multiple Endocrine Neoplasia Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Multiple Endocrine Neoplasia Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Multiple Endocrine Neoplasia Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Multiple Endocrine Neoplasia Treatment Market Size Markets, 2021 & 2028
  4.1.2 Drug Treatment
  4.1.3 Surgery Treatment
4.2 By Type - Global Multiple Endocrine Neoplasia Treatment Revenue & Forecasts
  4.2.1 By Type - Global Multiple Endocrine Neoplasia Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Multiple Endocrine Neoplasia Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Multiple Endocrine Neoplasia Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Multiple Endocrine Neoplasia Treatment Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Clinic
  5.1.4 Others
5.2 By Application - Global Multiple Endocrine Neoplasia Treatment Revenue & Forecasts
  5.2.1 By Application - Global Multiple Endocrine Neoplasia Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Multiple Endocrine Neoplasia Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Multiple Endocrine Neoplasia Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Multiple Endocrine Neoplasia Treatment Market Size, 2021 & 2028
6.2 By Region - Global Multiple Endocrine Neoplasia Treatment Revenue & Forecasts
  6.2.1 By Region - Global Multiple Endocrine Neoplasia Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Multiple Endocrine Neoplasia Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Multiple Endocrine Neoplasia Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Multiple Endocrine Neoplasia Treatment Revenue, 2017-2028
  6.3.2 US Multiple Endocrine Neoplasia Treatment Market Size, 2017-2028
  6.3.3 Canada Multiple Endocrine Neoplasia Treatment Market Size, 2017-2028
  6.3.4 Mexico Multiple Endocrine Neoplasia Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Multiple Endocrine Neoplasia Treatment Revenue, 2017-2028
  6.4.2 Germany Multiple Endocrine Neoplasia Treatment Market Size, 2017-2028
  6.4.3 France Multiple Endocrine Neoplasia Treatment Market Size, 2017-2028
  6.4.4 U.K. Multiple Endocrine Neoplasia Treatment Market Size, 2017-2028
  6.4.5 Italy Multiple Endocrine Neoplasia Treatment Market Size, 2017-2028
  6.4.6 Russia Multiple Endocrine Neoplasia Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Multiple Endocrine Neoplasia Treatment Market Size, 2017-2028
  6.4.8 Benelux Multiple Endocrine Neoplasia Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Multiple Endocrine Neoplasia Treatment Revenue, 2017-2028
  6.5.2 China Multiple Endocrine Neoplasia Treatment Market Size, 2017-2028
  6.5.3 Japan Multiple Endocrine Neoplasia Treatment Market Size, 2017-2028
  6.5.4 South Korea Multiple Endocrine Neoplasia Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Multiple Endocrine Neoplasia Treatment Market Size, 2017-2028
  6.5.6 India Multiple Endocrine Neoplasia Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Multiple Endocrine Neoplasia Treatment Revenue, 2017-2028
  6.6.2 Brazil Multiple Endocrine Neoplasia Treatment Market Size, 2017-2028
  6.6.3 Argentina Multiple Endocrine Neoplasia Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Multiple Endocrine Neoplasia Treatment Revenue, 2017-2028
  6.7.2 Turkey Multiple Endocrine Neoplasia Treatment Market Size, 2017-2028
  6.7.3 Israel Multiple Endocrine Neoplasia Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Multiple Endocrine Neoplasia Treatment Market Size, 2017-2028
  6.7.5 UAE Multiple Endocrine Neoplasia Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 West Coast Pharmaceuticals
  7.1.1 West Coast Pharmaceuticals Corporate Summary
  7.1.2 West Coast Pharmaceuticals Business Overview
  7.1.3 West Coast Pharmaceuticals Multiple Endocrine Neoplasia Treatment Major Product Offerings
  7.1.4 West Coast Pharmaceuticals Multiple Endocrine Neoplasia Treatment Revenue in Global Market (2017-2022)
  7.1.5 West Coast Pharmaceuticals Key News
7.2 Solvay
  7.2.1 Solvay Corporate Summary
  7.2.2 Solvay Business Overview
  7.2.3 Solvay Multiple Endocrine Neoplasia Treatment Major Product Offerings
  7.2.4 Solvay Multiple Endocrine Neoplasia Treatment Revenue in Global Market (2017-2022)
  7.2.5 Solvay Key News
7.3 Unicure India
  7.3.1 Unicure India Corporate Summary
  7.3.2 Unicure India Business Overview
  7.3.3 Unicure India Multiple Endocrine Neoplasia Treatment Major Product Offerings
  7.3.4 Unicure India Multiple Endocrine Neoplasia Treatment Revenue in Global Market (2017-2022)
  7.3.5 Unicure India Key News
7.4 Sun Pharmaceuticals Industries
  7.4.1 Sun Pharmaceuticals Industries Corporate Summary
  7.4.2 Sun Pharmaceuticals Industries Business Overview
  7.4.3 Sun Pharmaceuticals Industries Multiple Endocrine Neoplasia Treatment Major Product Offerings
  7.4.4 Sun Pharmaceuticals Industries Multiple Endocrine Neoplasia Treatment Revenue in Global Market (2017-2022)
  7.4.5 Sun Pharmaceuticals Industries Key News
7.5 Macleods Pharmaceuticals
  7.5.1 Macleods Pharmaceuticals Corporate Summary
  7.5.2 Macleods Pharmaceuticals Business Overview
  7.5.3 Macleods Pharmaceuticals Multiple Endocrine Neoplasia Treatment Major Product Offerings
  7.5.4 Macleods Pharmaceuticals Multiple Endocrine Neoplasia Treatment Revenue in Global Market (2017-2022)
  7.5.5 Macleods Pharmaceuticals Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Multiple Endocrine Neoplasia Treatment Market Opportunities & Trends in Global Market
Table 2. Multiple Endocrine Neoplasia Treatment Market Drivers in Global Market
Table 3. Multiple Endocrine Neoplasia Treatment Market Restraints in Global Market
Table 4. Key Players of Multiple Endocrine Neoplasia Treatment in Global Market
Table 5. Top Multiple Endocrine Neoplasia Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Multiple Endocrine Neoplasia Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Multiple Endocrine Neoplasia Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Multiple Endocrine Neoplasia Treatment Product Type
Table 9. List of Global Tier 1 Multiple Endocrine Neoplasia Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Multiple Endocrine Neoplasia Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Multiple Endocrine Neoplasia Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Multiple Endocrine Neoplasia Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Multiple Endocrine Neoplasia Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Multiple Endocrine Neoplasia Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Multiple Endocrine Neoplasia Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Multiple Endocrine Neoplasia Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Multiple Endocrine Neoplasia Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Multiple Endocrine Neoplasia Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Multiple Endocrine Neoplasia Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Multiple Endocrine Neoplasia Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Multiple Endocrine Neoplasia Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Multiple Endocrine Neoplasia Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Multiple Endocrine Neoplasia Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Multiple Endocrine Neoplasia Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Multiple Endocrine Neoplasia Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Multiple Endocrine Neoplasia Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Multiple Endocrine Neoplasia Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Multiple Endocrine Neoplasia Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Multiple Endocrine Neoplasia Treatment Revenue, (US$, Mn), 2023-2028
Table 30. West Coast Pharmaceuticals Corporate Summary
Table 31. West Coast Pharmaceuticals Multiple Endocrine Neoplasia Treatment Product Offerings
Table 32. West Coast Pharmaceuticals Multiple Endocrine Neoplasia Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Solvay Corporate Summary
Table 34. Solvay Multiple Endocrine Neoplasia Treatment Product Offerings
Table 35. Solvay Multiple Endocrine Neoplasia Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Unicure India Corporate Summary
Table 37. Unicure India Multiple Endocrine Neoplasia Treatment Product Offerings
Table 38. Unicure India Multiple Endocrine Neoplasia Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Sun Pharmaceuticals Industries Corporate Summary
Table 40. Sun Pharmaceuticals Industries Multiple Endocrine Neoplasia Treatment Product Offerings
Table 41. Sun Pharmaceuticals Industries Multiple Endocrine Neoplasia Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Macleods Pharmaceuticals Corporate Summary
Table 43. Macleods Pharmaceuticals Multiple Endocrine Neoplasia Treatment Product Offerings
Table 44. Macleods Pharmaceuticals Multiple Endocrine Neoplasia Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Multiple Endocrine Neoplasia Treatment Segment by Type in 2021
Figure 2. Multiple Endocrine Neoplasia Treatment Segment by Application in 2021
Figure 3. Global Multiple Endocrine Neoplasia Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Multiple Endocrine Neoplasia Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Multiple Endocrine Neoplasia Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Multiple Endocrine Neoplasia Treatment Revenue in 2021
Figure 8. By Type - Global Multiple Endocrine Neoplasia Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Multiple Endocrine Neoplasia Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Multiple Endocrine Neoplasia Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Multiple Endocrine Neoplasia Treatment Revenue Market Share, 2017-2028
Figure 12. US Multiple Endocrine Neoplasia Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Multiple Endocrine Neoplasia Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Multiple Endocrine Neoplasia Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Multiple Endocrine Neoplasia Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Multiple Endocrine Neoplasia Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Multiple Endocrine Neoplasia Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Multiple Endocrine Neoplasia Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Multiple Endocrine Neoplasia Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Multiple Endocrine Neoplasia Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Multiple Endocrine Neoplasia Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Multiple Endocrine Neoplasia Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Multiple Endocrine Neoplasia Treatment Revenue Market Share, 2017-2028
Figure 24. China Multiple Endocrine Neoplasia Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Multiple Endocrine Neoplasia Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Multiple Endocrine Neoplasia Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Multiple Endocrine Neoplasia Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Multiple Endocrine Neoplasia Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Multiple Endocrine Neoplasia Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Multiple Endocrine Neoplasia Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Multiple Endocrine Neoplasia Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Multiple Endocrine Neoplasia Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Multiple Endocrine Neoplasia Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Multiple Endocrine Neoplasia Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Multiple Endocrine Neoplasia Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Multiple Endocrine Neoplasia Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. West Coast Pharmaceuticals Multiple Endocrine Neoplasia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Solvay Multiple Endocrine Neoplasia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Unicure India Multiple Endocrine Neoplasia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Sun Pharmaceuticals Industries Multiple Endocrine Neoplasia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Macleods Pharmaceuticals Multiple Endocrine Neoplasia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)